Industry News

Kognitiv Corporation promotes Jisun Hahn to EVP and Chief Global Solutions Officer

Executive will play a critical role bridging the needs of global clients and innovative capabilities of Kognitiv's collaborative commerce platform TORONTO, Jan. 18, 2022 /PRNewswire/ -- Kognitiv Corporation, a global leader in the rapidly expanding market for collaborative commerce, announces the...

2022-01-18 08:30 1865

Railsbank expands presence in APAC to support embedded finance experiences

SYDNEY, Jan. 18, 2022 /PRNewswire/ -- Railsbank , the leading global embedded finance experiences platform, is scaling up its presence inSingapore, Vietnam, Malaysia, and Australia. Rail...

2022-01-18 08:18 3111

OR and EVLOMO to collaborate further for rolling out 150kW DC Super-Fast Charging stations at about 100 PTT Stations in Thailand.

BANGKOK, Jan. 18, 2022 /PRNewswire/ -- OR (SET:OR), a flagship company of PTT Group operating the oil and retail businesses andThailand's leading fuel retailer announced to collaborate further withFlorida-based EVLOMO to expand EV charging network. The rollout will consist of 150kW DC Super-Fast ...

2022-01-18 08:14 3423

Seeing the forest for the trees: Cambodia commits to achieving carbon neutrality by 2050

PHNOM PENH, Cambodia, Jan. 18, 2022 /PRNewswire/ -- Cambodia begins the new year as the first nation inSoutheast Asia to publish a plan to achieve carbon neutrality by 2050. The roadmap, known officially as a "Long-term strategy for Carbon Neutrality (LTS4CN)", was submitted to the United Nations...

2022-01-18 08:03 2133

CStone announced two key phase 3 registrational clinical trials of sugemalimab completed patient enrollment

* Both trials investigate first-line treatment with sugemalimab combined with chemotherapy in patients with metastatic gastric adenocarcinoma (GC)/gastro-esophageal junction (GEJ) adenocarcinoma or esophageal squamous cell carcinoma (ESCC) * A significant milestone in our pipeline development...

2022-01-18 08:00 4806

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity

HANGZHOU, China and SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the initiation of patient dosing in its Phase2b clinica...

2022-01-18 08:00 3709

Partners Capital Continues Expansion of Senior Leadership with Five Promotions and Three New Senior Hires

BOSTON, Jan. 18, 2022 /PRNewswire/ -- Partners Capital Investment Group announced the promotion of five senior executives, including three new Partners and two new Managing Directors, as well as three new senior hires. Partners Capital is a leading global Outsourced Investment Office with over$46...

2022-01-18 08:00 2162

GKN Powder Metallurgy announces Diego Laurent as Chief Executive Officer

- Diego Laurent is appointed Chief Executive Officer of GKN Powder Metallurgy with immediate effect.Diego Laurent moves from the position of Chief Financial Officer of GKN Powder Metallurgy, which he has held since 2018. - Peter Oberparleiter, who has been leading the company as Chief Executive ...

2022-01-18 07:50 5427

Telit FN980 5G Module Certified for Use on Telstra's 5G Sub-6 GHz Network

* The Telit FN980 gives Australia's businesses an economical solution for leveraging the speed and coverage of Telstra's 5G network in sub-6 GHz spectrum * Multi-gigabit speeds and ultra-low network latency are ideal for demanding, bandwidth-intensive enterprise applications such as SD-WAN and...

2022-01-18 06:30 3312

QUAY SERVES UP STYLE THIS SUMMER AT THE 2022 AUSTRALIAN OPEN

MELBOURNE, Australia, Jan. 18, 2022 /PRNewswire/ -- Quay, a leading global eyewear brand, has announcedthey are a Proud Supporter of AO Retail for the 2022 Australian Open  for this year's highly anticipated two-week tennis event. Commencing on Monday, 17th January to Sunday,...

2022-01-18 06:00 82794

Electronic System Design Industry Logs 17% Year-Over-Year Revenue Growth in Q3 2021, ESD Alliance Reports

MILPITAS, Calif., Jan. 17, 2022 /PRNewswire/ -- Electronic System Design (ESD) industry revenue increased 17.1% year-over-year from$2,953.9 million to $3,458.1 million in Q3 2021, the ESD Alliance, a SEMI Technology Community, announced today in its latestElectronic Design Market Data (EDMD) repo...

2022-01-17 23:00 2230

Buybacks of series B shares in AB Electrolux during week 02, 2022

STOCKHOLM, Jan. 17, 2022 /PRNewswire/ -- During the period January 10 - January 14, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 427,890 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize ...

2022-01-17 22:45 2230

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

FLORENCE, Italy, Jan. 17, 2022 /PRNewswire/ -- The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant in...

2022-01-17 22:12 3639

Celgard and Farasis Settle, Celgard Adds Senior-China to the California Patent Case, and Celgard Moves the North Carolina Trade Secret Case Back to California

CHARLOTTE, N.C., Jan. 17, 2022 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LP, was successful in settling its patent litigation against several Farasis defendants inthe United States (U.S.) District Court for the Northern District ofCalifornia (NDCA). Celgard a...

2022-01-17 22:00 3979

Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, announced it has received approval of its Allplex™ SARS CoV-2 FluA/FluB/RSV Assay under Health Canada's Interim Order onJanuary 11. Seegene's Allplex™ SARS CoV-2 Flu...

2022-01-17 20:00 3219

Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today that it has delivered over five million COVID-19 tests toIsrael to help detect and mitigate the spread of the Omicron variant. The company sent 1.7 mill...

2022-01-17 20:00 3082

Frost & Sullivan Recognizes MCM Telecom as a Leader in Mexico and Latin America in the Unified Communications as a Service Corporate Sector

MEXICO CITY, Jan. 17, 2022 /PRNewswire/ -- Frost & Sullivan has recognized MCM Telecom as a growth and innovation leader in theFrost Radar™: Unified Communications-as-a-Service Market inLatin America and the Caribbean, 2021. By promoting corporate digital transformation and providing sophisticate...

2022-01-17 19:03 2341

Kuaishou Technology Appoints Mr. Jin Bing as Chief Financial Officer, reporting to Mr. Cheng Yixiao, the Chief Executive Officer

HONG KONG, Jan. 17, 2022 /PRNewswire/ -- Kuaishou Technology (HK:1024) (the "Company" or "Kuaishou"), a leading content community and social platform, today announces that its board of directors (the "Board") has appointed Mr.Jin Bing as the chief financial officer of the Company (the "CFO"), rep...

2022-01-17 18:30 4123

Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab), a Subcutaneously Administered PD-L1 Antibody for Functional Cure of Chronic Hepatitis B

-- Estimated 1.59 million chronic hepatitis B (CHB) patients in the U.S. -- Interim results of the Phase IIb trial conducted on CHB patients in China showed that in patients with the baseline hepatitis B surface antigen (HBsAg) level ≤ 500 IU/mL, approximately 19% (3/16) of patients in the treatm...

2022-01-17 18:12 4750

HTPE Leads JYSSBIO to Close Series B+ Funding

HANGZHOU, China, Jan. 17, 2022 /PRNewswire/ -- Huatai International Private Equity Fund ("HTPE"), the Greater China focused private equity investment platform under Huatai Securities, is pleased to announce that it led the Series B+ financing ofZhejiang JYSS Bio-Engineering Co., Ltd.  ("JYSSBIO" ...

2022-01-17 17:58 4602